Jim Simons - Renaissance Technologies LLC 13F Activity & Position Changes (Q1 2023)

According to the SEC 13F filed on May 12, 2023, the Renaissance Technologies LLC portfolio showed several notable changes in holdings as of quarter-end Mar 31, 2023. The activity included new positions, additions to existing holdings, reductions, and complete exits, providing a clear view of how the portfolio evolved during the quarter.

During Q1 2023, the filing reported:

These updates highlight how the portfolio adjusted across different sectors and market conditions, offering insights into allocation shifts and investment trends.

Date Symbol Type Change Qty
Q1 2023
A
Agilent Technologies, Inc.
Buy - Position Entry
+544,200
Q1 2023
AA
Alcoa Corporation
Sell
-439,400
Q1 2023
AAAU
Goldman Sachs Physical Gold ETF
Buy - Position Entry
+94,400
Q1 2023
AADI
Aadi Bioscience, Inc.
Buy
+74,502
Q1 2023
AAL
American Airlines Group, Inc.
Buy
+6,471,132
Q1 2023
Buy - Position Entry
+9,785
Q1 2023
AAME
Atlantic American Corporation
Buy
+400
Q1 2023
AAN
Buy
+236,900
Q1 2023
AAOI
Applied Optoelectronics, Inc.
Buy
+17,800
Q1 2023
AAON
AAON, Inc.
Buy
+57,800
Q1 2023
AAP
Advance Auto Parts Inc.
Buy - Position Entry
+291,750
Q1 2023
AAPL
Apple Inc.
Sell
-7,090,086
Q1 2023
AAT
American Assets Trust, Inc.
Sell
-119,100
Q1 2023
AAXJ
iShares MSCI All Country Asia e
Buy
+100
Q1 2023
ABBNY
ABB Ltd.
Sell
-279,700
Q1 2023
ABBV
AbbVie Inc.
Sell
-15,900
Q1 2023
ABCL
AbCellera Biologics Inc.
Buy
+689,100
Q1 2023
ABEO
Abeona Therapeutics Inc.
Sell
-25,800
Q1 2023
ABEV
Ambev S.A.
Buy
+11,204,526
Q1 2023
ABG
Asbury Automotive Group Inc
Buy - Position Entry
+19,800
Q1 2023
Buy
+4,500
Q1 2023
ABM
ABM Industries Incorporated
Buy - Position Entry
+56,700
Q1 2023
ABNB
Airbnb, Inc.
Sell
-2,548,190
Q1 2023
ABOS
Acumen Pharmaceuticals, Inc.
Buy
+5,145
Q1 2023
ABSI
Absci Corporation
Buy
+194,993
Q1 2023
ABT
Abbott Laboratories
Buy
+1,742,500
Q1 2023
ABUS
Arbutus Biopharma Corporation
Buy
+239,855
Q1 2023
AC
Associated Capital Group, Inc.
Buy
+100
Q1 2023
ACA
Arcosa, Inc.
Sell
-76,600
Q1 2023
ACAD
ACADIA Pharmaceuticals Inc.
Sell
-197,900
Page 1 of 120